Ferrill F. Rose

The Wallerian degeneration slow (Wld(s)) gene does not attenuate disease in a mouse model of spinal muscular atrophy.

Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Induced pluripotent stem cells from a spinal muscular atrophy patient.

Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy.

The spinal muscular atrophy mouse model, SMAΔ7, displays altered axonal transport without global neurofilament alterations.

Transgenic inactivation of murine myostatin does not decrease the severity of disease in a model of Spinal Muscular Atrophy.